发明名称 Benzimidazole derivatives and their use as KDR kinase protein inhibitors
摘要 The invention discloses and claims benzimidazole compounds of formula (I): wherein X is C-R2; Y is C-R2 or C-R3; W and Z are each C-R3; R1 is an optionally substituted aryl, heteroaryl or a saturated 5- or 6-membered monocyclic heterocyclic radical or a bicyclic heterocyclic radical; and A5 is H or alkyl; or a stereoisomer, a racemate, an enantiomer or a diastereoisomer of said compound of formula (I) or a pharmaceutically acceptable salt thereof; the use of compounds of formula (I) for the treatment of a disorder of proliferation of blood vessels, uncontrolled angiogenesis, a fibrotic disorder, a disorder of proliferation of mesangial cells, a metabolic disorder, allergy, asthma, thrombosis, a disease of the nervous system, retinopathy, psoriasis, rheumatoid arthritis, diabetes, muscle degeneration, solid tumors and cancers, pharmaceutical compositions comprising a compound of formula (I) and one or more pharmaceutically acceptable adjuvants or diluents and pharmaceutical compositions comprising a compound of formula (I) and one or more. antimitiotic agents.
申请公布号 US2005009894(A1) 申请公布日期 2005.01.13
申请号 US20040828012 申请日期 2004.04.20
申请人 AVENTIS PHARMA S.A. 发明人 BABIN DIDIER;LE BRUN ALAIN;GAUZY-LAZO LAURENCE;BOUCHARD HERVE
分类号 C07D491/056;A61K31/4184;A61K31/4188;A61K31/4439;A61K31/454;A61K31/496;A61K31/5377;A61P3/00;A61P3/10;A61P7/02;A61P9/10;A61P11/06;A61P17/06;A61P19/02;A61P21/00;A61P25/00;A61P27/02;A61P29/00;A61P35/00;A61P37/08;A61P43/00;C07D401/14;C07D403/04;C07D403/14;C07D405/14;C07D409/14;C07D413/14;C07D487/04;C07D491/04;C07D491/052;C07D521/00;(IPC1-7):A61K31/419;A61K31/418;C07D471/02 主分类号 C07D491/056
代理机构 代理人
主权项
地址